The evolution of very-low-calorie diets: an update and meta-analysis (Q36599341)

15 August 2017

0 references

1 reference

title

The evolution of very-low-calorie diets: an update and meta-analysis (English)

1 reference

15 August 2017

1 reference

2

Thomas A Wadden

1 reference

15 August 2017

Adam Gilden Tsai

1

1 reference

15 August 2017

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

14

1 reference

15 August 2017

1283-1293

1 reference

15 August 2017

8

1 reference

Systematic review: an evaluation of major commercial weight loss programs in the United States

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Very Low Calorie Diets: Their Efficacy, Safety, and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Relationship of weight loss to cardiovascular risk factors in morbidly obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Meta-analysis: surgical treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Discrepancy between self-reported and actual caloric intake and exercise in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Long-term weight-loss maintenance: a meta-analysis of US studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

A comparison of two very-low-calorie diets: protein-sparing-modified fast versus protein-formula-liquid diet.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Mood and appetite during minimal-carbohydrate and carbohydrate-supplemented hypocaloric diets.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Responsible and irresponsible use of very-low-calorie diets in the treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Very low energy diets in the treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Very-low-calorie diets and sustained weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Gallstone formation during weight-reduction dieting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Cholelithiasis in patients treated with a very-low-calorie diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Reduced risk of liver-function-test abnormalities and new gallstone formation with weight loss on 3350-kJ (800-kcal) formula diets.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Sudden death associated with very low calorie weight reduction regimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Valvular heart disease associated with fenfluramine-phentermine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Food-containing hypocaloric diets are as effective as liquid-supplement diets for obese individuals with NIDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Controlled trial of the metabolic effects of a very-low-calorie diet: short- and long-term effects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Long-term evaluation of cardiac function in obese patients treated with a very-low-calorie diet: a controlled clinical study of patients without underlying cardiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

A controlled comparison of three very-low-calorie diets: effects on weight, body composition, and symptoms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Severe vs moderate energy restriction with and without exercise in the treatment of obesity: efficiency of weight loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

VLCD versus LCD in long-term treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Intermittent vs continuous VLCD therapy in obesity treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Weight management: a comparison of existing dietary approaches in a work-site setting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Long-term effects of a very low calorie diet (Nutrilett) in obesity treatment. A prospective, randomized, comparison between VLCD and a hypocaloric diet+behavior modification and their combination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

VLCD plus dietary and behavioural support versus support alone in the treatment of severe obesity. A randomised two-year clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Comparison of behavior therapy with and without very-low-energy diet in the treatment of morbid obesity. A 5-year outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Meta-analysis in clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Exercise as an adjunct to weight loss and maintenance in moderately obese subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Central nervous system control of food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Socioeconomic status and weight control practices among 20- to 45-year-old women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Metabolic and weight-loss effects of a long-term dietary intervention in obese patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Dieting and the development of eating disorders in obese women: results of a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Weight management using a meal replacement strategy: meta and pooling analysis from six studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Liquid meal replacement vs traditional food: a potential model for women who cannot maintain eating habit change

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Liquid meal replacements and glycemic control in obese type 2 diabetes patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Weight control in the physician's office

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Dietary treatment and long-term weight loss and maintenance in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

A descriptive study of individuals successful at long-term maintenance of substantial weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Relapse prevention training and problem-solving therapy in the long-term management of obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Randomized trial of lifestyle modification and pharmacotherapy for obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

Low and very low calorie diets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

7 January 2021

One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

7 January 2021

Maintenance following a very-low-calorie diet

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

7 January 2021

Diminished weight loss and behavioral compliance during repeated diets in obese patients with Type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

7 January 2021

Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

7 January 2021

Enhancing the efficacy of behavior therapy for obesity: effects of aerobic exercise and a multicomponent maintenance program

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

7 January 2021

Effects of four maintenance programs on the long-term management of obesity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.146

7 January 2021

Identifiers

DOI

10.1038/OBY.2006.146

1 reference

15 August 2017

1 reference

PubMed ID

16988070